Page 1,895«..1020..1,8941,8951,8961,897..1,9001,910..»

Category Archives: Transhuman News

Method improves single-cell genome analysis – Chemical & Engineering News (subscription)

Posted: April 17, 2017 at 12:27 pm

Genomic changes in individual cells can eventually lead to cancer or other diseases. So scientists would like to be able to sequence the genome in a single cell. But the methods to do so can be plagued by the preferential amplification of some regions of the genome over others, leading to incomplete sequence coverage.

A team led by X. Sunney Xie of Harvard University and Peking University has developed a whole-genome amplification method that reduces such bias and errors (Science 2017, DOI: 10.1126/science.aak9787).

In the method, called LIANTI, researchers fragment genomic DNA from a single cell by inserting pieces of DNA called transposons. The transposons tag the DNA fragments so that they get amplified linearly instead of exponentially. The amplified DNA is then used to generate a library for subsequent DNA sequencing.

Compared with other whole-genome amplification methods, LIANTI has more uniform amplification and higher sequence coverage. The method enabled the detection of a type of mutation called copy-number variation, which involves the gain or loss of regions of the genome, which is hard to detect with high resolution using other amplification methods. The researchers were even able to characterize so-called micro-copy-number variations, which are smaller than 100,000 bases, with a resolution of about 10,000 bases.

Xie and coworkers used this ability to detect gains and losses of sequences to show that initiation of DNA replication is random and differs from cell to cell. They also showed that many single-nucleotide variations detected in previous single-cell sequencing are artifacts caused by instability of the DNA bases.

Originally posted here:
Method improves single-cell genome analysis - Chemical & Engineering News (subscription)

Posted in Genome | Comments Off on Method improves single-cell genome analysis – Chemical & Engineering News (subscription)

University of California, Davis researchers publish lettuce genome assembly – Produce Grower (press release)

Posted: at 12:27 pm

The researchers made the announcement in Nature Communications.

UC Davis researchers have announced in Nature Communications that they have unlocked a treasure-trove of genetic information about lettuce and related plants, releasing the first comprehensive genome assembly for lettuce and the huge Compositae plant family, according to a press release.

Garden lettuce, or Lactuca sativa, is the plant species that includes a salad bars worth of lettuce types, ranging from iceberg to romaine. With an annual on-farm value of more than $2.4 billion, it is the most valuable fresh vegetable and one of the 10 most valuable crops, overall, in the United States.

Lettuce is a member of the huge Compositae family, which includes the good, the bad, and the ugly of the plant world, from the daisy and sunflower to ragweed and the dreaded star thistle.

The genome assembly a compilation of millions of DNA sequences into a useful genetic portrait provides researchers with a valuable tool for exploring Compositae familys many related plant species.

This genome assembly provides the foundation for numerous further genetic, evolutionary and functional studies of this whole family of plants, said Reyes-Chin-Wo, the lead author and graduate student in the laboratory of plant geneticist Richard Michelmore.

This is particularly significant because Compositae is the most successful family of flowering plants on earth in terms of the number of species and environments inhabited, said Richard Michelmore, who directs the UC Davis Genome Center.

Triplicate genes may explain success

The researchers found that specific genes in the lettuce genome were consistent with certain physical traits like the production of a rubber-containing milky sap that have also been found in taxonomically distinct species, such as the rubber tree.

The study also provided evidence that somewhere during the evolution of lettuce about 45 million years ago, its genome was triplicated. As a result, one-fourth of the genome appears in multiple related regions. Because such genomic duplications may give plant species an advantage in colonizing new environments, the ancient triplication event might, in part, explain the success of the Compositae plant family.

New technology yields more precise information

Michelmore noted that this is the first reported genome assembly of a plant species resulting from use of a new technology which gives information information about the physical proximity of the DNA sequences to which proteins are bound.

The new approach, developed by Dovetail Genomics, a company spun out from UC Santa Cruz, resulted in a more contiguous and accurate genome assembly, even though lettuce has one of the larger plant genomes sequenced to date, he said.

The sequencing was done in collaboration with the genomics firm BGI. Funding was provided by 10 plant breeding companies through the Lettuce Genomics Sequencing Consortium, UC Davis Genome Center, National Science Foundation and U.S. Department of Agriculture.

Go here to see the original:
University of California, Davis researchers publish lettuce genome assembly - Produce Grower (press release)

Posted in Genome | Comments Off on University of California, Davis researchers publish lettuce genome assembly – Produce Grower (press release)

Adam and the Genome Part One – Patheos (blog)

Posted: at 12:27 pm

D.R. Venema and Scot McKnight, Adam and the Genome, (Brazos, 2017).

On first blush the title of this book suggests an Indie rock band. But seriously, this is a very well researched book on genetics, and Biblical interpretation vis a vis the origins of human life, and whether or not Adam (and Eve) were historical persons. The genetics part of the book by D.R. Venema is a difficult read for those not familiar with genetics, even at the lay persons level, whereas, Scot McKnights half of the book (beginning at p. 93) is quite clear, but in some ways more problematic, from my point of view. Nonetheless, it is written with the sort of style and grace and honesty that we have come to expect in Scots books.

If we ask what prompted the book, all is made clearer by statements late in the study on pp. 172-73. The concern is about people losing their faith due to an encounter with science, particularly evolutionary theory, especially perhaps those who have come from more fundamentalist Protestant backgrounds. Scot deals regularly with such students and frames the matter this way: Here is what is vital for this book: [a] persons faith was challenged by his realization about evolution and he was forced to make a choice about whether the Bible or evolution was the truest description and understanding of the world. He chose science because the understanding of the Bible was in his view demonstrably wrong. Dennis and I are proposing another alternative: accepting the reality of genetic evidence supporting a theory of evolution along with an understanding of Adam and Eve that is more in turn with the historical context of Genesis.

In other words, the interpretation of the Word should be adjusted on the basis of the assumed fait accompli of science to demonstrate it has the facts on its side. Neither side of these assumptions, the science or the Biblical interpretation assumptions are without their problems. But I absolutely agree that we need to have a good discussion about this because science is one thing and pseudo-science that denies the geological and genetic evidence for an old earth and ancient human race needs to countered.

See the original post:
Adam and the Genome Part One - Patheos (blog)

Posted in Genome | Comments Off on Adam and the Genome Part One – Patheos (blog)

Gene salad: Lettuce genome assembly published – Phys.Org

Posted: at 12:27 pm

April 12, 2017 by Pat Bailey Richard Michelmore, director of the UC Davis Genome Center, and colleagues have released the first comprehensive genome assembly for lettuce and the huge Compositae plant family, which includes diverse plants ranging from the sunflower to star thistle. Credit: Gregory Urquiaga/UC Davis

Today (April 12), UC Davis researchers announced in Nature Communications that they have unlocked a treasure-trove of genetic information about lettuce and related plants, releasing the first comprehensive genome assembly for lettuce and the huge Compositae plant family.

Garden lettuce, or Lactuca sativa, is the plant species that includes a salad bar's worth of lettuce types, ranging from iceberg to romaine. With an annual on-farm value of more than $2.4 billion, it is the most valuable fresh vegetable and one of the 10 most valuable crops, overall, in the United States.

Lettuce is a member of the huge Compositae family, which includes the good, the bad, and the ugly of the plant world, from the daisy and sunflower to ragweed and the dreaded star thistle.

The genome assemblya compilation of millions of DNA sequences into a useful genetic portraitprovides researchers with a valuable tool for exploring the Compositae family's many related plant species.

"This genome assembly provides the foundation for numerous further genetic, evolutionary and functional studies of this whole family of plants," said Sebastian Reyes-Chin-Wo, the lead author and a graduate student in the laboratory of plant geneticist Richard Michelmore.

"This is particularly significant because Compositae is the most successful family of flowering plants on earth in terms of the number of species and environments inhabited," said Richard Michelmore, who directs the UC Davis Genome Center.

Triplicate genes may explain success:

The researchers found that specific genes in the lettuce genome were consistent with certain physical traitslike the production of a rubber-containing milky sapthat have also been found in taxonomically distinct species, such as the rubber tree.

The study also provided evidence that somewhere during the evolution of lettuce about 45 million years ago, its genome was "triplicated." As a result, one-fourth of the genomeincluding about 30 percent of all of its identified genesnow appears in multiple related regions. Because such genomic duplications may give plant species an advantage in colonizing new environments, the ancient triplication event might, in part, explain the success of the Compositae plant family.

New technology yields more precise information:

Michelmore noted that this is the first reported genome assembly of a plant species resulting from use of a new technology that gives information about the physical proximity of the DNA sequences to which proteins are bound.

The new approach, developed by Dovetail Genomics, a company spun out from UC Santa Cruz, resulted in a more contiguous and accurate genome assembly, even though lettuce has one of the larger plant genomes sequenced to date, he said.

Explore further: Sequencing hundreds of nuclear genes in the sunflower family now possible

More information: Sebastian Reyes-Chin-Wo et al, Genome assembly with in vitro proximity ligation data and whole-genome triplication in lettuce, Nature Communications (2017). DOI: 10.1038/ncomms14953

Journal reference: Nature Communications

Provided by: UC Davis

Advances in DNA sequencing technologies have enormous potential for the plant sciences. With genome-scale data sets obtained from these new technologies, researchers are able to greatly improve our understanding of evolutionary ...

As vegetable growers face a lack of skilled farm labor and higher production costs, they are searching for effective, lower-cost mechanical means of getting their products to market. In a study in the February 2016 issue ...

Researchers from the University of Bristol have uncovered one of the reasons for the evolutionary success of flowering plants.

Like most annuals, lettuce plants live out their lives in quiet, three-act dramas that follow the seasons. Seed dormancy gives way to germination; the young plant emerges and grows; and finally in the climax of flowering, ...

Prickly lettuce, a common weed that has long vexed farmers, has potential as a new cash crop providing raw material for rubber production, according to Washington State University scientists.

U.S. Department of Agriculture (USDA) scientists in California have developed 16 new lettuce breeding lines. Lettuce production in the United States is concentrated mostly in California and Arizona, where it is grown year-round. ...

Scientists at the University of California, Davis have discovered that DNA sequences thought to be essential for gene activity can be expendable. Sequences once called junk sometimes call the shots instead.

The hot springs of Yellowstone National Park may be extreme environments, but they are host to a diversity of microbes that could shed light on the evolution of life on Earth and, perhaps, what lurks on distant planets.

Breaks in DNA can wreak havoc in the body, giving rise to cancer and other health problems. Yet sometimes cells rupture their own DNA for a good reason.

How some industrial pollutants or abnormal levels of cellular metabolites contribute to diverse human diseases is now more clearly understood, based on a new study from the University of Wisconsin Carbone Cancer Center (UWCCC) ...

Cocaine, nicotine, capsaicin. These are just three familiar examples of the hundreds of thousands of small molecules (also called specialized or secondary metabolites) that plants use as chemical ammunition to protect themselves ...

A Florida Museum of Natural History study provides new insights into the complex, shared history between blood-sucking lice and the vitamin-producing bacterial sidekicks that enable them to parasitize mammals, including primates ...

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

See the original post here:
Gene salad: Lettuce genome assembly published - Phys.Org

Posted in Genome | Comments Off on Gene salad: Lettuce genome assembly published – Phys.Org

The Last Person Born in the 1800s Died and So Will You – Gizmodo

Posted: at 12:27 pm

Humans start getting ready to die as soon as they are born. But for some, that process takes a whole lot longer than it does for everyone else.

Take Italys Emma Morano. She was officially the worlds best live-r before passing away at 117 on Saturday, according to The Chicago Tribune. She was born on November 29, 1899Guinness World Records says that would have made her the last known person born in the 19th century. What do you do to live that old?

You do nothing. It just happens. Then you die anyway.

In the world of aging sciences, if you want to live a long life, choose long-lived parents, S. Jay Olshansky, Professor in the School of Public Health at the University of Illinois at Chicago, told Gizmodo. Thats always rule number one. Olshansky, a human longevity expert, walked us through how aging really works.

As a courtesy, newspapers always ask the oldest living person what their secret is. Morano said she ended an abusive marriage and ate raw eggs and cookies. Jeanne Louise Calment used to be the oldest person ever and lived to 122; she ate two pounds of chocolate per week and quit smoking at 119. Thats nice, but those lifestyle choiceswhere they lived and what they ate probably didnt do much.

Lifestyle is far from the whole story when it comes to your lifespan. There are a lot more people alive today compared with when Morano was born, so there will naturally be a lot more centenarians in the future. The world population has increased over 4 times since 1900, and the infant mortality rate has dropped a whole lot, from 100 babies per 1000 in 1900 to around 7 per 1000 births in 1999, according to the Centers for Disease Control and Prevention. Were treating diseases better, and our geriatric care is adding years onto people who may have died at 90, said Olshansky.

That means most of the things you can do to lengthen your life are being done for you already. Your decisions can only shorten it. We expose ourselves to the sun, we dont exercise, we eat things we shouldnt be eating, he said. Theres lots of things we can do to accelerate the aging process, but decelerating it is still a mystery.

As far as how the centenarians get to live so long, Olshansky believes their biological clocks simply tick slower (and that those of women tick slower than those of men). The visible aging processes and physiological signs like cell division might happen at a slower rate, possibly due to genetic factorshe pointed out that really old folks generally look younger throughout their life. But this is something that lots of folks around the world are still researching.

So, you will die, the decisions youre making are probably making your life shorter, you probably wont live to be 100, and if you do, its not because you drank red wine, snorted antioxidants or bathed in coconut oil. You got lucky. Chaos reigns.

[Chicago Tribune, Guinness World Records]

Go here to see the original:
The Last Person Born in the 1800s Died and So Will You - Gizmodo

Posted in Human Longevity | Comments Off on The Last Person Born in the 1800s Died and So Will You – Gizmodo

Psoriasis Topicals: National Psoriasis Foundation awards Seal of Recognition to 5 products – Outbreak News Today

Posted: at 12:25 pm

Recognized for easing psoriasis symptoms of dry, itchy, flaky skin, five products have recently been awarded the National Psoriasis Foundation (NPF) Seal of Recognition. The NPF Seal of Recognition highlights over-the-counter products that are proven to safely and effectively manage symptoms of psoriasis.

Independently reviewed by a panel of dermatology medical experts as well as those living with psoriasis, the Seal of Recognition identifies tested and trusted products that help people with psoriasis ease their symptoms. Joining a list of eight other products that have already received the Seal of Recognition, the latest Seal recipients include:

MetaDerm Heal & Prevent Cream. MetaDerm Heal & Prevent Cream is clinically proven to restore skin health and relieve itchy, red, scaly and inflamed skin, even for chronic and severe psoriasis. A unique combination of novel therapeutic botanicals helps to calm the damaging hyper-inflammation that causes skin to flare up.

Curl HYDRA THERAPY WET SKIN MOISTURIZER is activated by water on freshly-showered skin and penetrates deeply into the skins surface to heal dryness, for soft, healthy skin you can only imagine.

Dermarest Psoriasis Medicated Treatment Gel with 3% salicylic acid, and a unique zinc complex is specially formulated to truly treat psoriasis and relieve symptoms. This fragrance-free gel removes scales, eliminates itching, reduces redness, and restores moisture.

Dermarest Psoriasis Medicated Shampoo Plus Conditioner with 3% salicylic acid and a unique zinc complex is specially formulated to truly treat psoriasis and relieve symptoms. This fragrance-free shampoo plus conditioner removes and controls scalp build-up, soothes irritation, eliminates itching, and restores moisture.

Dermarest Psoriasis Medicated Moisturizer with 2% salicylic acid and a unique zinc complex is specially formulated to truly treat psoriasis and relieve symptoms. This soothing, fragrance-free moisturizer removes scales, eliminates itching, reduces redness, and restores moisture.

LISTEN:Psoriasis: An interview with Dr. David Sikes

View original post here:
Psoriasis Topicals: National Psoriasis Foundation awards Seal of Recognition to 5 products - Outbreak News Today

Posted in Psoriasis | Comments Off on Psoriasis Topicals: National Psoriasis Foundation awards Seal of Recognition to 5 products – Outbreak News Today

Health Watch: How to treat psoriasis – Newton Press Mentor

Posted: at 12:25 pm

TIP OF THE WEEK Simple solutions to care for psoriasis If you have psoriasis, medicines are your best treatment solution, but theyre not your only option. Complement your regimen with these strategies from WebMD. -- Moisturize. Whether you prefer creams or lotions, a moisturizing routine will improve your skin and your psoriasis. -- Spend some time in the sun. Sunlight is actually good for your psoriasis, provided you dont get sunburned. Try to spend 20 minutes a day, 3 days a week, in the sun. Always apply sunscreen with SPF 30 or higher to protect against burns. -- Stop smoking. Yes, you can add problems with your psoriasis to the list of smoking-related complications. One study showed smokers who smoked a pack a day were twice as likely to experience a serious case of psoriasis as those who smoked no more than half a pack a day.

HEALTHY EATING 3 tips to make dinner healthier, faster These days youre always on the go. When its time to eat, you reach for something fast, which often is not the healthiest choice. Fast and healthy dont have to be mutually exclusive. You can eat well without a lot of prep time, thanks to these tips from WebMD. -- Opt for precooked meats. Meat from your grocers deli or fresh over-the-counter fish are easy, healthy sources of protein. -- Choose a vegetarian selection. Eliminate the meat and you dont need to cook it. Vegetarian entrees offer a wide array of options for any taste, so explore your choices and add what appeals to you. -- Start with salad. Whether you go meatless or not, a salad makes for a quick, easy meal that can be as light or hearty as you want. Prepackaged options can save you even more time.

ILLNESS When to wash to prevent illness Can frequent hand-washing keep you from getting sick so often? Absolutely, says the Centers for Disease Control and Prevention. It points to research showing good hand-washing habits have reduced the incidence of diarrhea by 31 percent and the incidence of respiratory illness (including colds) by 21 percent.

Most everyone knows to wash their hands after using the bathroom and before eating, but the CDC also recommends stepping to the sink in the following four situations: -- Before, during and after preparing or handling food. -- After blowing your nose, coughing or sneezing. -- After touching garbage. -- After touching either an animal or animal food.

RESEARCH New procedure for damaged rotator cuffs The rotator cuff is one of the most important parts of the shoulder, as it consists of muscles and tendons that hold the shoulder in place and allow the body to lift the arm and reach for items. Rotator cuff injuries are the most common source of shoulder pain and disability. Those who suffer from rotator cuff disease often avoid surgery to repair the tear due to rehabilitation and time away from work.

A new technology is now available that helps tendons heal by stimulating the growth of new tendon tissue. The Rotation Medical Bioinductive Implant, which is about the size of a postage stamp, is inserted through a small incision during a short, minimally invasive procedure. The first-of-its-kind implant can provide a range of potential benefits, including shorter rehabilitation, faster recovery, prevention or slowing of disease progression, healing of partial-thickness tears, and decreased risk of developing a subsequent tear. -- Brandpoint

Visit link:
Health Watch: How to treat psoriasis - Newton Press Mentor

Posted in Psoriasis | Comments Off on Health Watch: How to treat psoriasis – Newton Press Mentor

Dermatology – Stanford University School of Medicine …

Posted: at 12:24 pm

Researchers named Outstanding Investigators by the National Cancer Institute-Howard Chang, Professor of Dermatology isfeaturedthis article...Full Article

How to reduce wrinkles without lasers or chemicals - S. Tyler Hollmig, Clinical Assistant professor of Dermatology is featured in this article...Full Article

Stanford team is growing healthy skin for ill patients-Jean Tang, Associate Professor of Dermatology;Peter Marinkovich, Associate Professor of Dermatology; andAnthony Oro, Professor of Dermatology are quoted in this article...Full Article

KGO TV- Filmmakers Tap Quarterback Legend To Fight Skin Cancer - Susan Swetter, MD, Stanford Professor of Dermatology isfeatured in this article...Full Article

Automated dermatologist' detects skin cancer with expert accuracy- Roberto Novoa, Clinical Assistant Professor is featured in this article...Full Article

Deep learning algorithm does as well as dermatologists in identifying skin cancer- Susan Swetter, MD, Justin Ko, MD MBA, Roberto Novoa, MD are featured in this article...Full Article

Gene therapy for blistering skin disease appears to enhance healing in clinical trial- Peter Marinkovich, MD, andJean Tang, MD, PhD, Associate Professors of Dermatologyare featured in this articleFull Article

Factors to consider before genetic testing -Joyce Teng, Clinical Associate Professor of Dermatology is featured in this articleFull Article

USPSTF: Not enough proof for visual skin Ca screening- Susan Swetter, MD, Stanford Professor of Dermatology is quoted in this article...Full Article

Possible psoriasis drug target identified - Peter Marinkovich, MD, Stanford Associate Professor of Dermatology is featured in this articleFull Story

5 Questions: Susan Swetter on choosing a sunscreen-Susan Swetter, MD, Stanford Professorof Dermatology is featured in this article....Full Article

Acne treatments: A Q&A with Stanford dermatologist Justin Ko-Justin Ko, MD, MBA, Stanford clinical assistant professor of Dermatology is featured in this article....Full Article

Ultraviolet light-induced Mutation Drives Many Skin Cancers-Paul Khavari, MD, PhD, Carl J Herzog Professor of Dermatology and chair of the Department of Dermatology is quoted on this study...Full Story

Disproportionate Rates of Melanoma Found in Marin County-Stanford professor of Dermatology, Susan Swetter, MD,, is featured in this audio forum...Audio

Antifungal drug may treat common skin cancer, study finds-Stanford associate professor of Dermatology, Jean Tang, MD, PhD, is featured in this article...Full Story

Inflammatory skin damage in mice blocked by bleach solution, study finds...Thomas Leung, MD, PhD, Stanford instructor of Dermatology and lead author comments....Full Story

New study: Genes may affect skin youthfulness...Anne Lynn S Chang, MD, Stanford assistant professor of Dermatology comments....SCOPE Blog

Melanoma deaths more likely in young men than women...Susan Swetter, MD., professor of Dermatology at Stanford is quoted....Full Story

See SCOPE Blog

How to weather summer's health challenges...Playing it safe in the sun...Susan Swetter, MD and Brooks Bahr, MD., Stanford Dermatologists are featured....See Newsletter

In The News Archive

Current Newsletter

Original post:
Dermatology - Stanford University School of Medicine ...

Posted in Gene Medicine | Comments Off on Dermatology – Stanford University School of Medicine …

Gene-Eden-VIR/Novirin vs. Antiviral Drugs, CBCD Reports High Interest in the Comparison Between Natural … – Yahoo Finance

Posted: at 12:24 pm

VALLEY COTTAGE, N.Y., April 17, 2017 /PRNewswire/ -- The Center for the Biology of Chronic Disease (CBCD) is happy to announce that the YouTube video "Natural treatment vs. Acyclovir (Zovirax) and other antiviral drugs" has gained more than half a million views. The video is available at https://youtu.be/kJzAYDEEJt0. In the video, Dr. Hanan Polansky and Dr. Edan Itzkovitz describe a clinical study that compared the natural antiviral treatment Gene-Eden-VIR/Novirin to the three antiviral drugs Acyclovir, Valacyclovir, and Famciclovir. The study showed that the natural treatment is more effective and safer than the drugs. The results of the study were published in two important peer-reviewed medical journals, Drug Design, Development and Therapy (1), and Clinical and Translational Medicine (2).

The study included 139 participants. The treatment was one to four capsules of Gene-Eden VIR/Novirin per day over a period of 2-48 months. The study included three controls recommended by the US Food and drug Administration (FDA). The study showed that Gene-Eden-VIR/Novirin safely and effectively decreased the frequency and duration of genital herpes outbreaks. The treatment was highly successful, 90.8% of the participants reported a decrease in the number of outbreaks, and 87% reported a decrease in the duration of their outbreaks.

The study published in Drug Design, Development and Therapy compared the effects of the natural antiviral treatment on the frequency of genital herpes outbreaks with the effects of the three drugs. It is important to note that these drugs are widely used by doctors as the first-line treatment in genital herpes. Remarkably, the results showed that Gene-Eden-VIR/Novirin is more effective.

The study published in Clinical and Translational Medicine recommends "suppressive (or long term) treatment with Gene-Eden-VIR/Novirin as a natural alternative to both suppressive (long term) and episodic (short term) treatments with current drugs, in both severe and mild genital herpes cases." Unlike acyclovir, valacyclovir, and famciclovir, that have known adverse effects, long time users of Gene-Eden-VIR/Novirin reported no adverse effects.

Both papers are indexed on Pubmed.com. See http://www.ncbi.nlm.nih.gov/pubmed/27621592 and https://www.ncbi.nlm.nih.gov/pubmed/27766602. Pubmed is a free search engine that lists abstracts in biomedicine and life sciences. Pubmed is maintained by the United States National Library of Medicine (NLM), at the National Institutes of Health (NIH).

According to Dr. Hanan Polansky, the lead author of both studies, "When it comes to my health, I believe in science. I am happy that the public does too."

Gene-Eden-VIR/Novirin consists of five natural ingredients, quercetin, a green tea extract, a cinnamon extract, a licorice extract, and selenium. The Gene-Eden-VIR/Novirin formula is patent protected. The formula was developed to target latent (hidden) viruses. Gene-Eden-VIR/Novirin was introduced in the marketplace at the end of 2009, and Novirin in 2014.

Media contact: Mike Davis The Center for the Biology of Chronic Disease (CBCD) 155086@email4pr.com 585-250-9999

(1) Hanan Polansky, Adrian Javaherian, and Edan Itzkovitz. Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and Famciclovir. Drug Des Devel Ther. 2016; 10: 27132722. (2) Hanan Polansky, Edan Itzkovitz, and Adrian Javaherian. Clinical study of Gene-Eden-VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases. Clin Transl Med. 2016 Dec;5(1):40. Epub 2016 Oct 20.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/gene-eden-virnovirin-vs-antiviral-drugs-cbcd-reports-high-interest-in-the-comparison-between-natural-treatments-and-approved-drugs-300440150.html

View post:
Gene-Eden-VIR/Novirin vs. Antiviral Drugs, CBCD Reports High Interest in the Comparison Between Natural ... - Yahoo Finance

Posted in Gene Medicine | Comments Off on Gene-Eden-VIR/Novirin vs. Antiviral Drugs, CBCD Reports High Interest in the Comparison Between Natural … – Yahoo Finance

Gene Therapy Technologies, Markets and Companies Report 2017: Profiles of 187 Companies with 232 Collaborations – GlobeNewswire (press release)

Posted: at 12:24 pm

April 17, 2017 09:48 ET | Source: Research and Markets

Dublin, April 17, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Gene Therapy - Technologies, Markets and Companies" to their offering.

Gene therapy technologies are described in detail including viral vectors, nonviral vectors and cell therapy with genetically modified vectors. Gene therapy is an excellent method of drug delivery and various routes of administration as well as targeted gene therapy are described. There is an introduction to technologies for gene suppression as well as molecular diagnostics to detect and monitor gene expression.

Clinical applications of gene therapy are extensive and cover most systems and their disorders. Full chapters are devoted to genetic syndromes, cancer, cardiovascular diseases, neurological disorders and viral infections with emphasis on AIDS. Applications of gene therapy in veterinary medicine, particularly for treating cats and dogs, are included.

Research and development is in progress in both the academic and the industrial sectors. The National Institutes of Health (NIH) of the US is playing an important part. As of 2015, over 2050 clinical trials have been completed, are ongoing or have been approved worldwide.A breakdown of these trials is shown according to the geographical areas and applications.

Gene therapy markets are estimated for the years 2016-2026. The estimates are based on epidemiology of diseases to be treated with gene therapy, the portion of those who will be eligible for these treatments, competing technologies and the technical developments anticipated in the next decades. In spite of some setbacks, the future for gene therapy is bright.The markets for DNA vaccines are calculated separately as only genetically modified vaccines and those using viral vectors are included in the gene therapy markets

Profiles of 187 companies involved in developing gene therapy are presented along with 232 collaborations. There were only 44 companies involved in this area in 1995. In spite of some failures and mergers, the number of companies has increased more than 4-fold within a decade. These companies have been followed up since they were the topic of a book on gene therapy companies by the author of this report. John Wiley & Sons published the book in 2000 and from 2001 to 2003, updated versions of these companies (approximately 160 at mid-2003) were available on Wiley's web site. Since that free service was discontinued and the rights reverted to the author, this report remains the only authorized continuously updated version on gene therapy companies.

Key Topics Covered:

Part I: Technologies & Markets

0. Executive Summary

1. Introduction

2. Gene Therapy Technologies

3. Clinical Applications of Gene Therapy

4. Gene Therapy of Genetic Disorders

5. Gene Therapy of Cancer

6. Gene Therapy of Neurological Disorders

7. Gene Therapy of Cardiovascular Disorders

8. Gene therapy of viral infections

9. Research, Development and Future of Gene Therapy

10. Regulatory, Safety, Ethical Patent Issues of Gene Therapy

11. Markets for Gene Therapy

12. References

Part II: Companies

13. Companies involved in Gene Therapy

For more information about this report visit http://www.researchandmarkets.com/research/d5gdwq/gene_therapy

Related Articles

Research and Markets Logo

LOGO URL | Copy the link below

Formats available:

Read the original:
Gene Therapy Technologies, Markets and Companies Report 2017: Profiles of 187 Companies with 232 Collaborations - GlobeNewswire (press release)

Posted in Gene Medicine | Comments Off on Gene Therapy Technologies, Markets and Companies Report 2017: Profiles of 187 Companies with 232 Collaborations – GlobeNewswire (press release)

Page 1,895«..1020..1,8941,8951,8961,897..1,9001,910..»